Compare DRD & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRD | PBH |
|---|---|---|
| Founded | 1895 | 1996 |
| Country | South Africa | United States |
| Employees | 3410 | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | N/A | 2004 |
| Metric | DRD | PBH |
|---|---|---|
| Price | $21.10 | $48.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $32.63 | ★ $75.33 |
| AVG Volume (30 Days) | 367.0K | ★ 682.7K |
| Earning Date | 08-19-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.91 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $39.23 | N/A |
| Revenue Next Year | $30.12 | $4.31 |
| P/E Ratio | $15.32 | ★ $12.40 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $13.25 | $42.62 |
| 52 Week High | $39.37 | $77.45 |
| Indicator | DRD | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 39.48 | 52.03 |
| Support Level | $20.13 | $44.86 |
| Resistance Level | $32.74 | $49.57 |
| Average True Range (ATR) | 0.82 | 1.59 |
| MACD | 0.10 | 0.30 |
| Stochastic Oscillator | 40.58 | 70.86 |
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.